Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Perlman

Showing results (221-230 of 275) with videos related to

Pageof 28
Sort By:
JCI Insight|March 8, 2024
A T cell-based SARS-CoV-2 spike protein vaccine provides protection without antibodiesJuan Shi, Jian Zheng, Xiujuan Zhang, et al.
Plos Pathogens|September 19, 2022
SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected miceSherif A El-Kafrawy, Abby Odle, Aymn T Abbas, et al.
Cell Reports|April 12, 2025
SIRT2 suppresses aging-associated cGAS activation and protects aged mice from severe COVID-19Marine Barthez, Biyun Xue, Jian Zheng, et al.
Peerj|May 16, 2022
An open source and convenient method for the wide-spread testing of COVID-19 using deep throat sputum samplesSunny C Huang, Thomas K Pak, Cameron P Graber, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2017
Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin miceKun Li, Christine L Wohlford-Lenane, Rudragouda Channappanavar, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2021
Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infectionChamandi S Dampalla, Jian Zheng, Krishani Dinali Perera, et al.
The Journal of Biological Chemistry|August 20, 2014
The cellular redox environment alters antigen presentationJonathan A Trujillo, Nathan P Croft, Nadine L Dudek, et al.
BMJ Open|May 14, 2026
How does prior infection and vaccination relate to the risk of incident SARS-CoV-2 infection/reinfection? A prospective cohort study among nine clinical sites in the USA, February 2021 to January 2023Ashley Judge, Erika T Beidelman, David B Allison, et al.
Journal of Virology|January 3, 2024
Adaptation of SARS-CoV-2 to ACE2<sub>H353K</sub> mice reveals new spike residues that drive mouse infectionKun Li, Abhishek Verma, Pengfei Li, et al.
Nature Communications|June 13, 2023
Omicron subvariant BA.5 efficiently infects lung cellsMarkus Hoffmann, Lok-Yin Roy Wong, Prerna Arora, et al.
Pageof 28

Showing results (221-230 of 275) with videos related to

Sort By:
Pageof 28
JCI Insight|March 8, 2024
A T cell-based SARS-CoV-2 spike protein vaccine provides protection without antibodiesJuan Shi, Jian Zheng, Xiujuan Zhang, et al.
Plos Pathogens|September 19, 2022
SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected miceSherif A El-Kafrawy, Abby Odle, Aymn T Abbas, et al.
Cell Reports|April 12, 2025
SIRT2 suppresses aging-associated cGAS activation and protects aged mice from severe COVID-19Marine Barthez, Biyun Xue, Jian Zheng, et al.
Peerj|May 16, 2022
An open source and convenient method for the wide-spread testing of COVID-19 using deep throat sputum samplesSunny C Huang, Thomas K Pak, Cameron P Graber, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2017
Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin miceKun Li, Christine L Wohlford-Lenane, Rudragouda Channappanavar, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2021
Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infectionChamandi S Dampalla, Jian Zheng, Krishani Dinali Perera, et al.
The Journal of Biological Chemistry|August 20, 2014
The cellular redox environment alters antigen presentationJonathan A Trujillo, Nathan P Croft, Nadine L Dudek, et al.
BMJ Open|May 14, 2026
How does prior infection and vaccination relate to the risk of incident SARS-CoV-2 infection/reinfection? A prospective cohort study among nine clinical sites in the USA, February 2021 to January 2023Ashley Judge, Erika T Beidelman, David B Allison, et al.
Journal of Virology|January 3, 2024
Adaptation of SARS-CoV-2 to ACE2<sub>H353K</sub> mice reveals new spike residues that drive mouse infectionKun Li, Abhishek Verma, Pengfei Li, et al.
Nature Communications|June 13, 2023
Omicron subvariant BA.5 efficiently infects lung cellsMarkus Hoffmann, Lok-Yin Roy Wong, Prerna Arora, et al.
Pageof 28